HIV‐1 Protease Inhibitors: Development, Status, and Potential Role in the Treatment of AIDS
- 1 January 1993
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 326 (12) , 921-924
- https://doi.org/10.1002/ardp.19933261202
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Novel dimeric penicillin derived inhibitors of HIV-1 proteinase: interaction with the catalytic aspartatesBioorganic & Medicinal Chemistry Letters, 1993
- Flavones are inhibitors of HIV-1 proteinaseBiochemical and Biophysical Research Communications, 1992
- L-687,908, a potent hydroxyethylene containing HIV protease inhibitorJournal of Medicinal Chemistry, 1991
- Design, Activity, and 2.8 Å Crystal Structure of a C 2 Symmetric Inhibitor Complexed to HIV-1 ProteaseScience, 1990
- Rational Design of Peptide-Based HIV Proteinase InhibitorsScience, 1990
- In vitro inhibition of HIV‐1 proteinase by ceruleninFEBS Letters, 1990
- Synthetic non-peptide inhibitors of HIV proteaseBiochemical and Biophysical Research Communications, 1989
- HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteinsBiochemical and Biophysical Research Communications, 1988
- The active site of aspartic proteinasesFEBS Letters, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983